Current and future therapies for Pseudomonas aeruginosa infection in patients with cystic fibrosis. (Q38635530)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28854668%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

title

Current and future therapies for Pseudomonas aeruginosa infection in patients with cystic fibrosis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28854668%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

main subject

cystic fibrosis

0 references

Pseudomonas aeruginosa

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28854668%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28854668%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28854668%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28854668%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28854668%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28854668%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28854668%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

Alain Filloux

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28854668%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

Wynne D Smith

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28854668%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

Emmanuelle Bardin

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28854668%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

Katie V Farrant

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28854668%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

Isaac Martin

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28854668%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

Andrew R Turnbull

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28854668%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

Natasha Wierre-Gore

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28854668%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

Eric W Alton

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28854668%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

Jacob G Bundy

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28854668%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

Andrew Bush

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28854668%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

Gary J Connett

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28854668%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

Paul S Freemont

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28854668%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

Andrew L Jones

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28854668%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

Zoltan Takats

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28854668%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

Jane C Davies

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28854668%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

publication date

1 August 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28854668%20AND%20SRC:MED&resulttype=core&format=json

FEMS Microbiology Letters

28 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28854668%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

volume

364

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28854668%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28854668%20AND%20SRC:MED&resulttype=core&format=json

Diagnostic and prognostic significance of systemic alkyl quinolones for P. aeruginosa in cystic fibrosis: A longitudinal study

28 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1093%2FFEMSLE%2FFNX121

Involvement of nitric oxide in biofilm dispersal of Pseudomonas aeruginosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSLE%2FFNX121

Garlic blocks quorum sensing and promotes rapid clearing of pulmonary Pseudomonas aeruginosa infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSLE%2FFNX121

Pyoverdine and proteases affect the response of Pseudomonas aeruginosa to gallium in human serum

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSLE%2FFNX121

Pseudomonas aeruginosa: all roads lead to resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSLE%2FFNX121

Antibiotic desensitization in adults with cystic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSLE%2FFNX121

Developments in novel breath tests for bacterial and fungal pulmonary infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSLE%2FFNX121

Cysteamine (Lynovex®), a novel mucoactive antimicrobial & antibiofilm agent for the treatment of cystic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSLE%2FFNX121

Phase II studies of nebulised Arikace in CF patients with Pseudomonas aeruginosa infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSLE%2FFNX121

Characterization of Inpatient Cystic Fibrosis Pulmonary Exacerbations

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSLE%2FFNX121

Growth phenotypes of Pseudomonas aeruginosa lasR mutants adapted to the airways of cystic fibrosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSLE%2FFNX121

Induced sputum to detect lung pathogens in young children with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSLE%2FFNX121

Value of serology in predicting Pseudomonas aeruginosa infection in young children with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSLE%2FFNX121

A phase 3, open-label, randomized trial to evaluate the safety and efficacy of levofloxacin inhalation solution (APT-1026) versus tobramycin inhalation solution in stable cystic fibrosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSLE%2FFNX121

A controlled trial of long-term inhaled hypertonic saline in patients with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSLE%2FFNX121

Cysteamine re-establishes the clearance of Pseudomonas aeruginosa by macrophages bearing the cystic fibrosis-relevant F508del-CFTR mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSLE%2FFNX121

A phase 3, multi-center, multinational, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of levofloxacin inhalation solution (APT-1026) in stable cystic fibrosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSLE%2FFNX121

Pyochelin potentiates the inhibitory activity of gallium on Pseudomonas aeruginosa.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSLE%2FFNX121

Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. The Pulmozyme Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSLE%2FFNX121

Bronchoalveolar lavage in children with cystic fibrosis: how many lobes should be sampled?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSLE%2FFNX121

Conformity of bacterial growth in sputum and contamination free endobronchial samples in patients with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSLE%2FFNX121

Influence of chelation strength and bacterial uptake of gallium salicylidene acylhydrazide on biofilm formation and virulence of Pseudomonas aeruginosa.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSLE%2FFNX121

Co-encapsulation of gallium with gentamicin in liposomes enhances antimicrobial activity of gentamicin against Pseudomonas aeruginosa.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSLE%2FFNX121

Clinical Significance of Microbial Infection and Adaptation in Cystic Fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSLE%2FFNX121

Pseudomonas aeruginosa in cystic fibrosis patients with G551D-CFTR treated with ivacaftor

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSLE%2FFNX121

OligoG CF-5/20 Disruption of Mucoid Pseudomonas aeruginosa Biofilm in a Murine Lung Infection Model

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSLE%2FFNX121

Inhibition of quorum sensing in Pseudomonas aeruginosa biofilm bacteria by a halogenated furanone compound.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSLE%2FFNX121

Negative control of quorum sensing by RpoN (sigma54) in Pseudomonas aeruginosa PAO1

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSLE%2FFNX121

Bronchoscopy following diagnosis with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSLE%2FFNX121

Restoring Cystic Fibrosis Transmembrane Conductance Regulator Function Reduces Airway Bacteria and Inflammation in People with Cystic Fibrosis and Chronic Lung Infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSLE%2FFNX121

Chromosomal mechanisms of aminoglycoside resistance in Pseudomonas aeruginosa isolates from cystic fibrosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSLE%2FFNX121

The multiple signaling systems regulating virulence in Pseudomonas aeruginosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSLE%2FFNX121

Regional Isolation Drives Bacterial Diversification within Cystic Fibrosis Lungs

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSLE%2FFNX121

The transition metal gallium disrupts Pseudomonas aeruginosa iron metabolism and has antimicrobial and antibiofilm activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSLE%2FFNX121

Overcoming drug resistance with alginate oligosaccharides able to potentiate the action of selected antibiotics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSLE%2FFNX121

Pseudomonas aeruginosa genotypes acquired by children with cystic fibrosis by age 5-years

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSLE%2FFNX121

Ga@C-dots as an antibacterial agent for the eradication of Pseudomonas aeruginosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSLE%2FFNX121

Biocompatible nano-gallium/hydroxyapatite nanocomposite with antimicrobial activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSLE%2FFNX121

Outcomes of adults with cystic fibrosis infected with antibiotic-resistant Pseudomonas aeruginosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSLE%2FFNX121

Gallium(III) complexes with 2-acetylpyridine-derived thiosemicarbazones: antimicrobial and cytotoxic effects and investigation on the interactions with tubulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSLE%2FFNX121

Longitudinal development of mucoid Pseudomonas aeruginosa infection and lung disease progression in children with cystic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSLE%2FFNX121

Antibacterial-resistant Pseudomonas aeruginosa: clinical impact and complex regulation of chromosomally encoded resistance mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSLE%2FFNX121

Pharmacokinetics and safety of panobacumab: specific adjunctive immunotherapy in critical patients with nosocomial Pseudomonas aeruginosa O11 pneumonia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSLE%2FFNX121

Pseudomonas aeruginosa pyocyanin induces neutrophil death via mitochondrial reactive oxygen species and mitochondrial acid sphingomyelinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSLE%2FFNX121

Evidence for periciliary liquid layer depletion, not abnormal ion composition, in the pathogenesis of cystic fibrosis airways disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSLE%2FFNX121

Direct detection of N-acylhomoserine lactones in cystic fibrosis sputum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSLE%2FFNX121

Anti-PcrV antibody in cystic fibrosis: a novel approach targeting Pseudomonas aeruginosa airway infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSLE%2FFNX121

Cyanide levels found in infected cystic fibrosis sputum inhibit airway ciliary function

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSLE%2FFNX121

Myeloperoxidase in human neutrophil host defence

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSLE%2FFNX121

High frequency of hypermutable Pseudomonas aeruginosa in cystic fibrosis lung infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSLE%2FFNX121

Antipseudomonal Bacteriophage Reduces Infective Burden and Inflammatory Response in Murine Lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSLE%2FFNX121

The role of chloride anion and CFTR in killing of Pseudomonas aeruginosa by normal and CF neutrophils

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSLE%2FFNX121

CFTR Expression in human neutrophils and the phagolysosomal chlorination defect in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSLE%2FFNX121

Antibiotic allergy in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSLE%2FFNX121

Quorum sensing inhibition in Pseudomonas aeruginosa biofilms: new insights through network mining.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSLE%2FFNX121

A nanoscale characterization of the interaction of a novel alginate oligomer with the cell surface and motility of Pseudomonas aeruginosa.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSLE%2FFNX121

The effect of alginate oligosaccharides on the mechanical properties of Gram-negative biofilms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSLE%2FFNX121

Side effects of aminoglycosides on the kidney, ear and balance in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSLE%2FFNX121

Early rise of anti-pseudomonas antibodies and a mucoid phenotype of pseudomonas aeruginosa are risk factors for development of chronic lung infection--a case control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSLE%2FFNX121

A New Class of Safe Oligosaccharide Polymer Therapy To Modify the Mucus Barrier of Chronic Respiratory Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSLE%2FFNX121

Down regulation of virulence factors of Pseudomonas aeruginosa by salicylic acid attenuates its virulence on Arabidopsis thaliana and Caenorhabditis elegans

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSLE%2FFNX121

Interplay of efflux system, ampC, and oprD expression in carbapenem resistance of Pseudomonas aeruginosa clinical isolates

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSLE%2FFNX121

Pyocyanin-enhanced neutrophil extracellular trap formation requires the NADPH oxidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSLE%2FFNX121

Redox warfare between airway epithelial cells and Pseudomonas: dual oxidase versus pyocyanin

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSLE%2FFNX121

Characterization of hydrogen peroxide production by Duox in bronchial epithelial cells exposed to Pseudomonas aeruginosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSLE%2FFNX121

Predictive Value of Oropharyngeal Cultures for Identifying Lower Airway Bacteria in Cystic Fibrosis Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSLE%2FFNX121

Screening for quorum-sensing inhibitors (QSI) by use of a novel genetic system, the QSI selector

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSLE%2FFNX121

Antibacterial properties of the CFTR potentiator ivacaftor

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSLE%2FFNX121

Diagnostic accuracy of oropharyngeal cultures in infants and young children with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSLE%2FFNX121

Gallium-mediated siderophore quenching as an evolutionarily robust antibacterial treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSLE%2FFNX121

The mucoid switch in Pseudomonas aeruginosa represses quorum sensing systems and leads to complex changes to stationary phase virulence factor regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSLE%2FFNX121

Social cheating in Pseudomonas aeruginosa quorum sensing

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSLE%2FFNX121

An "Unlikely" Pair: The Antimicrobial Synergy of Polymyxin B in Combination with the Cystic Fibrosis Transmembrane Conductance Regulator Drugs KALYDECO and ORKAMBI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSLE%2FFNX121

Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSLE%2FFNX121

Contribution of the MexXY Multidrug Transporter to Aminoglycoside Resistance in Pseudomonas aeruginosa Clinical Isolates

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSLE%2FFNX121

Peptidomimetic antibiotics target outer-membrane biogenesis in Pseudomonas aeruginosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSLE%2FFNX121

Origins of cystic fibrosis lung disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSLE%2FFNX121

Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSLE%2FFNX121

Pseudomonas eradication and clinical effectivness of Ivacaftor in four Hispanic patients with S549N.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSLE%2FFNX121

Toward implementation of quorum sensing autoinducers as biomarkers for infectious disease states

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSLE%2FFNX121

Early Eradication of Pseudomonas aeruginosa in Patients with Cystic Fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSLE%2FFNX121

Antibiotic prophylaxis in infants and young children with cystic fibrosis: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSLE%2FFNX121

Quorum sensing systems differentially regulate the production of phenazine-1-carboxylic acid in the rhizobacterium Pseudomonas aeruginosa PA1201.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSLE%2FFNX121

Early antibiotic treatment for Pseudomonas aeruginosa eradication in patients with cystic fibrosis: a randomised multicentre study comparing two different protocols

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSLE%2FFNX121

Azithromycin inhibits quorum sensing in Pseudomonas aeruginosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSLE%2FFNX121

Anti-Pseudomonas aeruginosa IgY antibodies augment bacterial clearance in a murine pneumonia model

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSLE%2FFNX121

Open label study of inhaled aztreonam for Pseudomonas eradication in children with cystic fibrosis: The ALPINE study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSLE%2FFNX121

A novel treatment of cystic fibrosis acting on-target: cysteamine plus epigallocatechin gallate for the autophagy-dependent rescue of class II-mutated CFTR

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSLE%2FFNX121

Fosfomycin/tobramycin for inhalation in patients with cystic fibrosis with pseudomonas airway infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSLE%2FFNX121

Alveolar inflammation in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSLE%2FFNX121

Effect of novel antibacterial gallium-carboxymethyl cellulose on Pseudomonas aeruginosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSLE%2FFNX121

Association between hypermutator phenotype, clinical variables, mucoid phenotype, and antimicrobial resistance in Pseudomonas aeruginosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSLE%2FFNX121

Phage therapy is highly effective against chronic lung infections with Pseudomonas aeruginosa.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSLE%2FFNX121

Cystic fibrosis microbiology: Advances in antimicrobial therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSLE%2FFNX121

Inhibition of lipopolysaccharide transport to the outer membrane in Pseudomonas aeruginosa by peptidomimetic antibiotics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSLE%2FFNX121

Quorum sensing and environmental adaptation in Pseudomonas aeruginosa: a tale of regulatory networks and multifunctional signal molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSLE%2FFNX121

Pyocyanin and 1-hydroxyphenazine produced by Pseudomonas aeruginosa inhibit the beating of human respiratory cilia in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSLE%2FFNX121

Redox reactions and microbial killing in the neutrophil phagosome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSLE%2FFNX121

A controlled clinical trial of a therapeutic bacteriophage preparation in chronic otitis due to antibiotic-resistant Pseudomonas aeruginosa ; a preliminary report of efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSLE%2FFNX121

Synthesis of cephalosporin-3'-diazeniumdiolates: biofilm dispersing NO-donor prodrugs activated by β-lactamase

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSLE%2FFNX121

Phage lysis: three steps, three choices, one outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSLE%2FFNX121

Microbiological yield from induced sputum compared to oropharyngeal swab in young children with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSLE%2FFNX121

Secondary electrospray ionization-mass spectrometry (SESI-MS) breathprinting of multiple bacterial lung pathogens, a mouse model study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSLE%2FFNX121

Robust detection of P. aeruginosa and S. aureus acute lung infections by secondary electrospray ionization-mass spectrometry (SESI-MS) breathprinting: from initial infection to clearance

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSLE%2FFNX121

Risk Factors for Bronchiectasis in Children with Cystic Fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSLE%2FFNX121

Rapid In Vivo Fingerprinting of Nonvolatile Compounds in Breath by Extractive Electrospray Ionization Quadrupole Time-of-Flight Mass Spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSLE%2FFNX121

21 January 2018

Identifiers

DOI

10.1093/FEMSLE/FNX121

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28854668%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28854668%20AND%20SRC:MED&resulttype=core&format=json